Option Circle | $3,000,000 | (Mar 12, 2026)
Standard Kernel Co. | $20,000,000 | (Mar 12, 2026)
Chowbus | $81,000,000 | (Mar 12, 2026)
Certified by Founder
Lodge
Inspire Biotherapeutics Inc
start up
Canada
- Toronto, Ontario
- 17/03/2023
- Pre-Seed
- Undisclosed Amount
Inspire has developed a lung tropic AAV gene therapy platform that has demonstrated transduction and long-term expression in lung tissue without impact on other tissue types in disease-relevant animal models. We are currently pursing initiation of a Proof-of-Concept clinical trial for a lethal neonatal lung disease with short time to data readout and success of therapy. The platform can then be applied to Cystic Fibrosis and other monogenic lung diseases.
- Industry Biotechnology Research
- Website https://www.inspirebiotx.com/
- LinkedIn https://www.linkedin.com/company/inspire-biotherapeutics-inc/people/
Related People
Sandra DonaldsonFounder
Canada -
Toronto, Ontario
VP & COO OIRM. CEO & COO, Inspire Biotherapeutics. Experienced executive with a demonstrated history of nurturing research networks into thriving ecosystems while working in biotechnology and clinical trial sectors.
zymtrace | $12,200,000 | (Mar 12, 2026)
AgentMail (YC S25) | $6,000,000 | (Mar 12, 2026)
Ernesta Inc. | $20,000,000 | (Mar 12, 2026)
Translucent AI | $27,000,000 | (Mar 12, 2026)
Xscape Photonics Inc | $37,000,000 | (Mar 12, 2026)
Swarm Aero | $35,000,000 | (Mar 12, 2026)
anchr | $5,800,000 | (Mar 12, 2026)
Verdant Impact | $3,000,000 | (Mar 11, 2026)
Imperium Technologies, Inc | $2,000,000 | (Mar 11, 2026)